News
Public · Published
Rocket Lab stock slides despite record backlog, upbeat outlook
Rocket Lab shares fell around 7% in premarket trading Tuesday after the company reported a wider-than-expected third-quarter loss of $0.12 per share. Revenue rose 72.7% year over year to a record $267.8 million, backlog reached about $3.6 billion, and the company forecast fourth-quarter revenue of $270 million to $290 million.
Published:
Updated:
What happened
Rocket Lab shares fell around 7% in premarket trading Tuesday after the company reported a wider-than-expected third-quarter loss of $0.12 per share. Revenue rose 72.7% year over year to a record $267.8 million, backlog reached about $3.6 billion, and the company forecast fourth-quarter revenue of $270 million to $290 million.
Confirmed
Global impact / market context
The results show strong demand and sales growth, but the larger-than-expected loss indicates the company is not yet converting that growth into expected profit. More contracts and a higher launch price may support future revenue, while delayed Neutron service means those missions are not imminent.
Analyst inference
Investors faced conflicting signals: record revenue, backlog and an above-consensus fourth-quarter forecast contrasted with a wider loss. The article reports a roughly 7% premarket share decline, suggesting the earnings shortfall outweighed positive demand indicators in the immediate reaction.
Analyst inference
What to watch
- Watch whether Rocket Lab delivers its forecast of $270 million to $290 million in fourth-quarter revenue; results below that range could weaken confidence in its growth outlook. Confirmed
- Track progress toward Neutron’s first launch, targeted no earlier than 2027, and the delivery of first-flight hardware to Launch Complex 3; delays could defer related contract revenue. Confirmed
- Look for evidence that higher launch prices and new contracts improve profit per sale, which means revenue remaining after costs; the article does not yet show that improvement. Analyst inference